GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
2 740,00 INR
arrow_upward
+0,98%(+26,60) 1D
20-ноя., 15:30:03 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
2 701,00 INR
High
2 748,00 INR
Low
2 680,00 INR
Mkt. cap
464,17 млд
Avg. vol.
94,32 миң
Volume
84,48 миң
Dividend
2,08%
Quarterly dividend
14,25 INR
Ex-dividend date
2026-ж., 29-май
P/E ratio
40,48
52-wk high
3 120,70 INR
52-wk low
2 088,10 INR
EPS
67,68 INR
Shares outstanding
169,41 млн
No. of employees
3 миң
Open
2 701,00 INR
High
2 748,00 INR
Low
2 680,00 INR
Mkt. cap
464,17 млд
Avg. vol.
94,32 миң
Volume
84,48 миң
Dividend
2,08%
Quarterly dividend
14,25 INR
Ex-dividend date
2026-ж., 29-май
P/E ratio
40,48
52-wk high
3 120,70 INR
52-wk low
2 088,10 INR
EPS
67,68 INR
Shares outstanding
169,41 млн
No. of employees
3 миң
News stories
From web sources and news partners
NPR
·
36 мүнөт мурун
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
WSJ
·
12 саат мурун
S&P 500 Flirts With Correction
Barron's
·
4 саат мурун
S&P 500’s Tech Sector Crosses Bear Market Threshold
The Motley Fool
·
1 саат мурун
If I Could Tell All S&P 500 Investors Just 1 Thing Right Now, It's This
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3,1 миң
Founded1924-ж., 13-ноя.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteindia-pharma.gsk.com